CSIMarket
 
Pear Therapeutics Inc   (PEAR)
 

Pear Therapeutics Inc reported Revenue of $4.083 millions, in the financial span closing Sep 30 2022

company delivered third quarter of 2022 operating deficit of $-26.629 millions


Published Mar 23 2023
CSIMarket Team / CSIMarket.com


Medical_ultrasound_examination_pd the Medical Equipment & Supplies company disclosed $4.083 millions, in Revenue in the third quarter of 2022.




For the third quarter of 2022 Pear Therapeutics Inc logged net shortfall of $-30.723 million, instead of earnings of $5.832 millions booked in the corresponding reporting season a year before.


Pear Therapeutics Inc is expected to report next financial earnings on May 15, 2023.



Pear Therapeutics Inc's Price to Cash Flow ratio

Pear Therapeutics Inc's Effective Tax Rate



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com